Keay Nakae

Chardan Capital Markets

Recent Articles

What Do Analysts Think About the Biopharma Set on Transforming Psychiatry 04/09/2026

Alto Neuroscience Inc. (ANRO:NYSE) is a clinical-stage biopharmaceutical company focused on transforming psychiatry through novel drug candidates.